NeoGenomics Inc (NEO) NPV

Sell:$12.89Buy:$13.40Price increased$0.33 (2.57%)

Prices delayed by at least 15 minutes
Sell:$12.89
Buy:$13.40
Change:Price increased$0.33 (2.57%)
Deal now
Prices delayed by at least 15 minutes
Sell:$12.89
Buy:$13.40
Change:Price increased$0.33 (2.57%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Key people

Warren Stone
President, Chief Operating Officer
Antony P. Zook
Chief Executive Officer, Director
Jeffrey Scott Sherman
Chief Financial Officer
Alicia Olivo
Executive Vice President, General Counsel & Business Development
Gregory Aunan
Chief Accounting Officer
Lynn A. Tetrault
Independent Chairman of the Board
Michael A. Kelly
Lead Independent Director
John P. Kenny
Director
Marjorie C. Green
Independent Director
Neil Gunn
Independent Director
Click to see more

Key facts

  • Shares in issue
    129.39m
  • EPIC
    NEO
  • ISIN
    US64049M2098
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • Market cap
    $1.64bn
  • Employees
    2,200
  • Exchange
    NASDAQ
  • Index
    S&P 600 Small Cap, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.